Key facts
- Beijing Advanced Medical Technologies’s last known valuation is $217.7M (Apr 2026).
- It has raised $29.0M; the latest was PE Growth/Expansion ($29.0M) in Apr 2026.
- Notable investors include Beijing Daxing Investment Group, China Medical System, Minsheng Securities Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Beijing Advanced Medical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Beijing Advanced Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beijing Advanced Medical Technologies
Manufacturer of implantable cardiovascular medical devices intended for intravascular therapies. The company's offerings include fully absorbable coronary stents, peripheral vascular stents, 3D multi axis precision printed stent products, intravascular implantable devices, interventional medical components, enabling improved mechanical performance, scalable production and next generation biodegradable treatment options for cardiovascular care.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2011
- Employees
- 70
- Website
- ametcorp.com/
- Ownership
- Privately Held (backing)
Beijing Advanced Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beijing Advanced Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beijing Advanced Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.